← Medication & Supplement Reference

VETERINARY TEAM REFERENCE · MEDICATION

Selegiline hydrochloride

Updated October 26, 2026 · Sources and review status below

For veterinarians and veterinary staff. Product-label information is distinct from extra-label clinical practice. This is not a complete prescribing formulary or an automated interaction screen. Verify the current label, exact formulation, patient and species-specific clinical reference before use. Independent veterinary/pharmacy review remains pending.

Prescribing overview

Anipryl controls canine cognitive dysfunction and uncomplicated pituitary-dependent hyperadrenocorticism.

Irreversible monoamine oxidase inhibitorProduct-specific clinical reference

Canine labeled indications only.

Key prescribing checks

  • Evaluate other causes of behavioral change.

Uses by species

Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.

Dogs

US veterinary label

Cognitive dysfunction; uncomplicated PDH

Use / indication source ↗

Pharmacology & pharmacokinetics

Mechanism and clinical role

Preferential MAO-B inhibition at recommended canine doses.

Absorption, distribution, metabolism and elimination

Extensive distribution; hepatic metabolites contribute pharmacologic activity.

SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC

Contraindications & cautions

Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.

Anipryl

Reviewed product labeling; human restrictions require veterinary interpretation unless an animal label is specified.

Contraindications · when not to use

  • Hypersensitivity.

Precautions & monitoring

  • Not recommended for aggression; concurrent PDH therapies unevaluated.

Species status describes the reviewed evidence, not permission to self-prescribe.

Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.

Adverse effects

Vomiting, diarrhea, restlessness, anorexia and neurologic signs.

These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.

Dosing & administration

Verify the source before prescribing. The regimens below summarize selected veterinary product labels, not every accepted veterinary use. They are not automatic substitutions between brands or formulations. Renal/hepatic disease, concurrent therapy, age, indication and clinical response can require a different plan.
Open weight-based dose calculator →
Selected product-label regimens — not a patient-specific prescription
Species & indicationLabeled regimenEligibility & source
DogsCanine cognitive dysfunctionAnipryl tablets

0.5–1.0 mg/kg

Oral · Once daily, preferably morning

Reassess response

Initially nearest whole tablet; veterinarian adjusts to tolerance.

Verify full dosing label ↗
DogsUncomplicated pituitary-dependent hyperadrenocorticismAnipryl tablets

1.0 mg/kg initially

Oral · Once daily, preferably morning

Reassess after two months

Veterinarian may increase to maximum 2 mg/kg/day if no improvement; reassess after one month at higher dose or any progression.

Verify full dosing label ↗

Only the cited canine Anipryl label regimen is shown.

Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗

Drug & supplement interactions

This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.

Compare with other medications and check species →

Anipryl

Reviewed product labeling; human restrictions require veterinary interpretation unless an animal label is specified.

  • Avoid antidepressants and interacting MAO-active drugs; prescriber-directed washout is essential.
Interaction source ↗

Monitoring

Clinical response and tolerance.

Client counseling

Disclose all medicines, cough preparations and parasite products.

This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.

Storage & handling

Follow the dispensed container; protect from children and accidental animal ingestion.

Brands, formulations & ingredient identity

Active ingredients

Selegiline hydrochloride

Anipryl is a canine tablet.

Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.

Anipryl

Formulation
Oral tablets
Label / product scope
Dogs

US canine label.

Product label / source ↗

References & review status

Clinical reference updated October 26, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.

Search another medication or supplement →

CONTINUE EXPLORING

Use these connected guides to prepare informed questions for your veterinary team.

Find Veterinary Care Near YouLocate general practices, urgent-care clinics, emergency hospitals and specialists.Read resource →When It Is an EmergencyRecognize signs that require immediate veterinary care.Read resource →Interactive Symptom NavigatorStart with what you notice and understand when to seek help.Read resource →Poisons and Household HazardsRecognize common exposures and avoid unsafe home treatment.Read resource →Printable Owner ToolkitBring observations, medication details and questions to your appointment.Read resource →
Privacy & cookie choices